Chemotherapy in non-small cell lung cancer: time to re-examine our attitudes.
Open Access
- 1 March 1996
- Vol. 51 (3), 231-232
- https://doi.org/10.1136/thx.51.3.231
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.Journal of Clinical Oncology, 1993
- Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer.Journal of Clinical Oncology, 1993
- A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance statusBritish Journal of Cancer, 1992
- Radiotherapy Alone Versus Combined Chemotherapy and Radiotherapy in Nonresectable Non-Small-Cell Lung Cancer: First Analysis of a Randomized Trial in 353 PatientsJNCI Journal of the National Cancer Institute, 1991
- International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USAThe Lancet, 1990
- Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 1990